Their products Provenge and CVac are based on similar technologies where the blood of the patient is taken out and treated then put back so that the patient's own body can fight the disease. Provenge is aimed at Prostate cancer and CVac ovarian cancer. Once established as treatments the obvious path is to go for other forms of cancer. Hope this is correct.
- Forums
- ASX - By Stock
- please explain .....
Their products Provenge and CVac are based on similar...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
32.8¢ |
Change
0.008(2.34%) |
Mkt cap ! $479.3M |
Open | High | Low | Value | Volume |
32.0¢ | 33.3¢ | 32.0¢ | $575.8K | 1.772M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 177251 | 32.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.0¢ | 458273 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 191227 | 0.325 |
18 | 291341 | 0.320 |
11 | 329219 | 0.315 |
11 | 92247 | 0.310 |
9 | 136983 | 0.305 |
Price($) | Vol. | No. |
---|---|---|
0.330 | 457825 | 17 |
0.335 | 185523 | 14 |
0.340 | 223113 | 9 |
0.345 | 192175 | 7 |
0.350 | 148064 | 12 |
Last trade - 11.58am 25/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
Previous Video
Next Video
SPONSORED BY The Market Online